UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000055889
Receipt number R000063871
Scientific Title A study to determine the effective timing and intensity of interventions to reduce the progression from impaired glucose tolerance to type 2 diabetes mellitus
Date of disclosure of the study information 2024/10/21
Last modified on 2024/10/20 21:21:13

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A study to determine the effective timing and intensity of interventions to reduce the progression from impaired glucose tolerance to type 2 diabetes mellitus

Acronym

A study to determine the effective timing and intensity of interventions to reduce the progression from impaired glucose tolerance to type 2 diabetes mellitus

Scientific Title

A study to determine the effective timing and intensity of interventions to reduce the progression from impaired glucose tolerance to type 2 diabetes mellitus

Scientific Title:Acronym

Study of timing and intensity of intervention for glucose impaired tolerance

Region

Japan


Condition

Condition

Impaired Glucose Tolerance (IGT)

Classification by specialty

Medicine in general Cardiology Endocrinology and Metabolism

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To determine the timing and intensity of interventions for persons with impaired glucose tolerance

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Hazard ratios for the development of type 2 diabetes mellitus

Key secondary outcomes



Base

Study type

Others,meta-analysis etc


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

19 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1. RCT trials investigating the effects of preventing the progression of type 2 diabetes mellitus
2. English language articles
3. Full-text available

Key exclusion criteria

1. Trials where inhibition of progression of type 2 diabetes mellitus has not been studied
2. Trials for which 2-hour post-load blood glucose values are not available
3. Trials not including IGT (subjects with normal glucose, impaired fasting glucose (IFG) only, diabetes mellitus, other diseases (e.g., nephropathy))
4. Adults (19 years of age or older)
5. Not pregnant
6. Trials examining drugs other than diabetes mellitus medications
7. Trials with a follow-up period of less than 6 months
8. Trials for which the number of events for the outcome is not available
9. Not an Article

Target sample size



Research contact person

Name of lead principal investigator

1st name Kotoba
Middle name
Last name Okuyama

Organization

Toho University

Division name

Department of Medical Statistics, Graduate School of Medicine

Zip code

143-8540

Address

5-21-16 Omori-nishi, Ota-ku, Tokyo 143-8540, Japan

TEL

03-3762-4151

Email

md19013o@st.toho-u.jp


Public contact

Name of contact person

1st name Kotoba
Middle name
Last name Okuyama

Organization

Toho University

Division name

Department of Medical Statistics, Graduate School of Medicine

Zip code

143-8540

Address

5-21-16 Omori-nishi, Ota-ku, Tokyo 143-8540, Japan

TEL

03-3762-4151

Homepage URL


Email

md19013o@st.toho-u.jp


Sponsor or person

Institute

Toho University

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

NA

Address

NA

Tel

NA

Email

NA


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2024 Year 10 Month 21 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2024 Year 10 Month 21 Day

Date of IRB


Anticipated trial start date

2024 Year 10 Month 21 Day

Last follow-up date

2024 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Information to be obtained from literature:
1. Follow-up period (mean or median)
2. Baseline 2-hour post-glucose glucose (group combined mean)
3. Mean change from baseline to the most recent post-intervention 2-hour post-glucose glucose level for each group
4. Baseline fasting blood glucose (group combined mean)
5. Mean change from baseline to most recent post-intervention fasting plasma glucose in each group
6. Baseline HbA1c (group combined mean)
7. Baseline age (combined group mean)
8. Baseline BMI (combined group mean)
9. Baseline IGT percentage (%)
10. Hazard ratio
11. Number of cases in each group and number of patients who progressed to type 2 diabetes mellitus

Risk of bias:
Assessed with the Cochrane risk of bias (RoB) Tool.

Statistical analysis: Meta-regression

Statistical analysis software: SAS 9.4 or higher


Management information

Registered date

2024 Year 10 Month 20 Day

Last modified on

2024 Year 10 Month 20 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000063871